AUXILIO MUTUO HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.6M
- Transactions
- 657
- Companies
- 29
- Average per transaction
- $3,944
Who reported the payments
| AbbVie | $1,012,371 |
| Beigene, Ltd. | $344,524 |
| Beone Medicines Ltd. | $317,404 |
| Eisai Inc. | $244,190 |
| Janssen Research & Development, LLC | $200,931 |
| Bristol Myers Squibb | $109,818 |
| Genentech, Inc. | $61,823 |
| E.r. Squibb & Sons, L.L.C. | $41,588 |
| ADC Therapeutics America, Inc. | $40,719 |
| Beone Medicines USA, Inc. | $39,426 |
| Intercept Pharmaceuticals, Inc. | $33,249 |
| AstraZeneca | $32,908 |
| Astrazeneca UK Limited | $27,750 |
| Eli Lilly | $23,300 |
| Mallinckrodt Hospital Products Inc. | $9,779 |
| Abbott | $9,000 |
| Sanofi US Services Inc. | $6,158 |
| Incyte Corporation | $6,000 |
| Intercept Pharma Europe Ltd. | $5,769 |
| Amgen | $5,424 |
| Takeda Pharmaceuticals U.S.A., Inc. | $4,250 |
| GE HealthCare | $3,647 |
| Genmab A/s | $3,500 |
| Beigene USA, Inc. | $3,500 |
| Johnson & Johnson | $2,500 |
| Merck | $1,000 |
| Bio-rad Laboratories, Inc. | $439 |
| Olympus Latin America, Inc. | $226 |
| National Marrow Donor Program | $75 |